Natera is a San Carlos, CA-based company that is driven by a passion for elevating the science and utility of prenatal testing. The advent of the Information Age has created a paradigm shift in the fields of computing and informatics. Surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing. Until Natera.
From conception to delivery, Natera is pioneering next-generation accuracy and reliability in preconception and prenatal genetic testing services, enabling couples to be informed about their pregnancy each step of the way. The company offers a wide range of tests from preimplantation genetic diagnosis (PGD) for IVF to breakthrough advances in the field of non-invasive prenatal testing (NIPT). Using advances from the human genome project and powered by sophisticated proprietary bioinformatic algorithms, Natera’s comprehensive portfolio of tests, proven science, and experienced genetic counseling services deliver the most accurate results in the industry.
Closing share price